<DOC>
	<DOCNO>NCT01118325</DOCNO>
	<brief_summary>The purpose study determine drug characteristic Ticagrelor , determine 4 week treatment reduce blood clotting .</brief_summary>
	<brief_title>An Asian Study Assess Properties Profile Ticagrelor Patients With Stable Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Any Percutaneous Coronary Intervention , 3 month prior randomization Previous document acute coronary syndrome ( ACS ) , 3 month prior randomisation Treatment ASA ACS , transient ischemic attack ( TIA ) , Stroke within 3 month prior randomisation Known concurrent disease stroke TIA atrial fibrillation Persons treat blood clot agent stop</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Stable Coronary Artery Disease</keyword>
	<keyword>Platelet Aggregation</keyword>
</DOC>